Central nervous system symptoms related to the use of efavirenz in HIV-seropositive patients

被引:3
作者
Wichers, M
van der Ven, A
Maes, M
机构
[1] Maastricht Univ, Dept Psychiat & Neuropsychol, NL-6200 MD Maastricht, Netherlands
[2] Acad Hosp Maastricht, Dept Microbiol, Maastricht, Netherlands
关键词
efavirenz; immune activation; neuropsychiatric side effects;
D O I
10.1097/00001504-200211000-00015
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Purpose of review Efavirenz is currently regarded as an effective first-line treatment for HIV infection. It is therefore important that possible side effects are well investigated. Recent findings The most frequent adverse events of efavirenz are central nervous system symptoms, such as depressive symptoms, insomnia, vivid nightmares, headache, dizziness, fatigue and impaired concentration. Summary Future research should focus on the neuropsychiatric side effects of efavirenz and on the mechanisms by which efavirenz induces side effects.
引用
收藏
页码:643 / 647
页数:5
相关论文
共 32 条
  • [1] Efavirenz
    Adkins, JC
    Noble, S
    [J]. DRUGS, 1998, 56 (06) : 1055 - 1064
  • [2] BARTLETT JG, 2001, J HOPKINS HOSP 2002
  • [3] Blanch J, 2001, J ACQ IMMUN DEF SYND, V27, P336, DOI 10.1097/00126334-200108010-00003
  • [4] Manic syndrome associated with efavirenz overdose
    Blanch, J
    Corbella, B
    García, F
    Parellada, E
    Gatell, JM
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 33 (02) : 270 - 271
  • [5] Role of IL-6 in cytokine-induced sickness behavior:: a study with IL-6 deficient mice
    Bluthé, RM
    Michaud, B
    Poli, V
    Dantzer, R
    [J]. PHYSIOLOGY & BEHAVIOR, 2000, 70 (3-4) : 367 - 373
  • [6] BONACCORSO S, 2000, IN PRESS J AFFECT DI
  • [7] Synergistic effects of interleukin-1β, interleukin-6, and tumor necrosis factor-α:: Central monoamine, corticosterone, and behavioral variations
    Brebner, K
    Hayley, S
    Zacharko, R
    Merali, Z
    Anisman, H
    [J]. NEUROPSYCHOPHARMACOLOGY, 2000, 22 (06) : 566 - 580
  • [8] Neurobehavioral effects of interferon-α in cancer patients:: Phenomenology and paroxetine responsiveness of symptom dimensions
    Capuron, L
    Gumnick, JF
    Musselman, DL
    Lawson, DH
    Reemsnyder, A
    Nemeroff, CB
    Miller, AH
    [J]. NEUROPSYCHOPHARMACOLOGY, 2002, 26 (05) : 643 - 652
  • [9] Adverse effects of antiretroviral therapy
    Carr, A
    Cooper, DA
    [J]. LANCET, 2000, 356 (9239) : 1423 - 1430
  • [10] Efavirenz-induced psychosis
    de la Garza, CLS
    Paoletti-Duarte, S
    García-Martín, C
    Gutiérrez-Casares, JR
    [J]. AIDS, 2001, 15 (14) : 1911 - 1912